Megakaryopoiesis: Transcriptional insights into megakaryocyte maturation

Frontiers in Bioscience

Volumn 12, Issue 6, 2007, Pages 2050-2062

  Kostyak, John C ^a   Naik, Ulhas P ^a,b  

^a UNIVERSITY OF DELAWARE   (United States)

^b University of Delaware   (United States)

Author keywords

Megakaryocyte; Megakaryopoiesis; Polyploidy; Review

Indexed keywords

MUS;

THROMBOPOIETIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 1;

ANIMAL; GENETIC TRANSCRIPTION; HUMAN; MEGAKARYOCYTE; METABOLISM; MOUSE; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE;

ANIMALS; BLOOD PLATELETS; GATA1 TRANSCRIPTION FACTOR; HUMANS; MEGAKARYOCYTES; MICE; SIGNAL TRANSDUCTION; THROMBOPOIETIN; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 36049010588     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2210     Document Type: Article

References (116)

1. Macaulay, I. C., P. Carr, A. Gusnanto, W. H. Ouwehand, D. Fitzgerald & N. A. Watkins: Platelet genomics and proteomics in human health and disease. J Clin Invest, 115, 3370-7 (2005) (Pubitemid 43121821)
2. Becker, R. P., and P.P. DeBruyn: The transmural passage of blood cells into myeloid sinusoids and the entry of platelets into the sinusoidal circulation; a scanning electron microscopic investigation. American Journal of Anatomy, 145, 1046-1052 (1976)
3. Yamada, E.: The fine structure of the megakaryocyte in the mouse spleen. Acta Anat (Basel), 29, 267-90 (1957)
4. Shaklai, M. & M. Tavassoli: Demarcation membrane system in rat megakaryocyte and the mechanism of platelet formation: a membrane reorganization process. J Ultrastruct Res, 62, 270-85 (1978) (Pubitemid 8360152)
5. Lichtman, M. A., J. K. Chamberlain, W. Simon & P. A. Santillo: Parasinusoidal location of megakaryocytes in marrow: a determinant of platelet release. Am J Hematol, 4, 303-12 (1978) (Pubitemid 9066765)
6. Behnke, O.: An electron microscope study of the rat megacaryocyte. II. Some aspects of platelet release and microtubules. J Ultrastruct Res, 26, 111-29 (1969)
7. Radley, J. M.: Ultrastructural aspects of platelet production. Prog Clin Biol Res, 215, 387-98 (1986)
8. Behnke, O. & A. Forer: From megakaryocytes to platelets: platelet morphogenesis takes place in the bloodstream. Eur J Haematol Suppl, 61, 3-23 (1998)
9. Hansen, M. & N. T. Pedersen: Circulating megakaryocytes in blood from the antecubital vein in healthy, adult humans. Scand J Haematol, 20, 371-6 (1978) (Pubitemid 8332263)
10. Tong, M., P. Seth & D. G. Penington: Proplatelets and stress platelets. Blood, 69, 522-8 (1987) (Pubitemid 17022023)
11. Zucker-Franklin, D. & C. S. Philipp: Platelet production in the pulmonary capillary bed: new ultrastructural evidence for an old concept. Am J Pathol, 157, 69-74 (2000) (Pubitemid 30641726)
12. Levine, R. F., A. Eldor, P. K. Shoff, S. Kirwin, D. Tenza & E. M. Cramer: Circulating megakaryocytes: delivery of large numbers of intact, mature megakaryocytes to the lungs. Eur J Haematol, 51, 233-46 (1993) (Pubitemid 24014153)
13. Aliberti, G., M. Proietta, I. Pulignano, L. Tritapepe, C. Di Giovanni, A. Schiappoli & G. Vercillo: The lungs and platelet production. Clin Lab Haematol, 24, 161-4 (2002) (Pubitemid 34639343)
14. Winkelmann, M., P. Pfitzer & W. Schneider: Significance of polyploidy in megakaryocytes and other cells in health and tumor disease. Klin Wochenschr, 65, 1115-31 (1987) (Pubitemid 17158704)
15. Tomer, A.: Human marrow megakaryocyte differentiation: multiparameter correlative analysis identifies von Willebrand factor as a sensitive and distinctive marker for early (2N and 4N)megakaryocytes. Blood, 104, 2722-7 (2004) (Pubitemid 39434953)
16. Corbel, C., P. Vaigot & J. Salaun: (alpha)IIb Integrin, a novel marker for hemopoietic progenitor cells. Int J Dev Biol, 49, 279-84 (2005) (Pubitemid 40917349)
17. Debili, N., F. Wendling, D. Cosman, M. Titeux, C. Florindo, I. Dusanter-Fourt, K. Schooley, N. Methia, M. Charon, R. Nador & et al.: The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. Blood, 85, 391-401 (1995)
18. Debili, N., L. Coulombel, L. Croisille, A. Katz, J. Guichard, J. Breton-Gorius & W. Vainchenker: Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow. Blood, 88, 1284-96 (1996) (Pubitemid 26276803)
19. Hunt, P.: A bipotential megakaryocyte/erythrocyte progenitor cell: the link between erythropiesis and megakaryopoiesis becomes stronger. J Lab Clin Med, 125, 303-4 (1995)
20. Tomer, A., L. A. Harker & S. A. Burstein: Flow cytometric analysis of normal human megakaryocytes. Blood, 71, 1244-52 (1988)
21. Lecine, P., J. E. Italiano, Jr., S. W. Kim, J. L. Villeval & R. A. Shivdasani: Hematopoietic-specific beta 1 tubulin participates in a pathway of platelet biogenesis dependent on the transcription factor NF-E2. Blood, 96, 1366-73 (2000) (Pubitemid 30658465)
22. Tiwari, S., J. E. Italiano, Jr., D. C. Barral, E. H. Mules, E. K. Novak, R. T. Swank, M. C. Seabra & R. A. Shivdasani: A role for Rab27b in NF-E2-dependent pathways of platelet formation. Blood, 102, 3970-9 (2003) (Pubitemid 37486978)
23. Souyri, M., I. Vigon, J. F. Penciolelli, J. M. Heard, P. Tambourin & F. Wendling: A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors. Cell, 63, 1137-47 (1990) (Pubitemid 120035063)
24. de Sauvage, F. J., P. E. Hass, S. D. Spencer, B. E. Malloy, A. L. Gurney, S. A. Spencer, W. C. Darbonne, W. J. Henzel, S. C. Wong, W. J. Kuang & et al.: Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature, 369, 533-8 (1994)
25. Kaushansky, K., S. Lok, R. D. Holly, V. C. Broudy, N. Lin, M. C. Bailey, J. W. Forstrom, M. M. Buddle, P. J. Oort, F. S. Hagen & et al.: Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature, 369, 568-71 (1994) (Pubitemid 24192526)
26. Lok, S., K. Kaushansky, R. D. Holly, J. L. Kuijper, C. E. Lofton-Day, P. J. Oort, F. J. Grant, M. D. Heipel, S. K. Burkhead, J. M. Kramer & et al.: Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature, 369, 565-8 (1994) (Pubitemid 24192525)
27. Wendling, F., E. Maraskovsky, N. Debili, C. Florindo, M. Teepe, M. Titeux, N. Methia, J. Breton-Gorius, D. Cosman & W. Vainchenker: cMpl ligand is a humoral regulator of megakaryocytopoiesis. Nature, 369, 571-4 (1994)
28. Bartley, T. D., J. Bogenberger, P. Hunt, Y. S. Li, H. S. Lu, F. Martin, M. S. Chang, B. Samal, J. L. Nichol, S. Swift & et al.: Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell, 77, 1117-24 (1994)
29. Wang, Z., J. Skokowa, A. Pramono, M. Ballmaier & K. Welte: Thrombopoietin regulates differentiation of rhesus monkey embryonic stem cells to hematopoietic cells. Ann N Y Acad Sci, 1044, 29-40 (2005) (Pubitemid 40967592)
30. Kelemen, E., I. Cserhati & B. Tanos: Demonstration and some properties of human thrombopoietin in thrombocythaemic sera. Acta Haematol, 20, 350-5 (1958)
31. Kaushansky, K.: Thrombopoietin: the primary regulator of megakaryocyte and platelet production. Thromb Haemost, 74, 521-5 (1995)
32. Kaushansky, K.: Thrombopoietin. N Engl J Med, 339, 746-54 (1998) (Pubitemid 28417359)
33. Eaton, D. L. & F. J. de Sauvage: Thrombopoietin: the primary regulator of megakaryocytopoiesis and thrombopoiesis. Exp Hematol, 25, 1-7 (1997) (Pubitemid 27063737)
34. Jelkmann, W.: The role of the liver in the production of thrombopoietin compared with erythropoietin. Eur J Gastroenterol Hepatol, 13, 791-801 (2001) (Pubitemid 32656592)
35. Gurney, A. L., W. J. Kuang, M. H. Xie, B. E. Malloy, D. L. Eaton & F. J. de Sauvage: Genomic structure, chromosomal localization, and conserved alternative splice forms of thrombopoietin. Blood, 85, 981-8 (1995)
36. Kato, T., A. Oda, Y. Inagaki, H. Ohashi, A. Matsumoto, K. Ozaki, Y. Miyakawa, H. Watarai, K. Fuju, A. Kokubo, T. Kadoya, Y. Ikeda & H. Miyazaki: Thrombin cleaves recombinant human thrombopoietin: one of the proteolytic events that generates truncated forms of thrombopoietin. Proc Natl Acad Sci U S A, 94, 4669-74 (1997) (Pubitemid 27194301)
37. Vigon, I., J. P. Mornon, L. Cocault, M. T. Mitjavila, P. Tambourin, S. Gisselbrecht & M. Souyri: Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily. Proc Natl Acad Sci U S A, 89, 5640-4 (1992)
38. Gurney, A. L., K. Carver-Moore, F. J. de Sauvage & M. W. Moore: Thrombocytopenia in c-mpl-deficient mice. Science, 265, 1445-7 (1994) (Pubitemid 24306797)
39. de Sauvage, F. J., K. Carver-Moore, S. M. Luoh, A. Ryan, M. Dowd, D. L. Eaton & M. W. Moore: Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J Exp Med, 183, 651-6 (1996) (Pubitemid 26059523)
40. Sattler, M., M. A. Durstin, D. A. Frank, K. Okuda, K. Kaushansky, R. Salgia & J. D. Griffin: The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases. Exp Hematol, 23, 1040-8 (1995)
41. Drachman, J. G., K. M. Millett & K. Kaushansky: Thrombopoietin signal transduction requires functional JAK2, not TYK2. J Biol Chem, 274, 13480-4 (1999)
42. Royer, Y., J. Staerk, M. Costuleanu, P. J. Courtoy & S. N. Constantinescu: Janus kinases affect thrombopoietin receptor cell surface localization and stability. J Biol Chem, 280, 27251-61 (2005) (Pubitemid 41040765)
43. Kaushansky, K.: The molecular mechanisms that control thrombopoiesis. J Clin Invest, 115, 3339-47 (2005) (Pubitemid 43121817)
44. Miyakawa, Y., P. Rojnuckarin, T. Habib & K. Kaushansky: Thrombopoietin induces phosphoinositol 3-kinase activation through SHP2, Gab, and insulin receptor substrate proteins in BAF3 cells and primary murine megakaryocytes. J Biol Chem, 276, 2494-502 (2001)
45. Cross, T. G., D. Scheel-Toellner, N. V. Henriquez, E. Deacon, M. Salmon & J. M. Lord: Serine/threonine protein kinases and apoptosis. Exp Cell Res, 256, 34-41 (2000) (Pubitemid 30211164)
46. Juhaszova, M., D. B. Zorov, S. H. Kim, S. Pepe, Q. Fu, K. W. Fishbein, B. D. Ziman, S. Wang, K. Ytrehus, C. L. Antos, E. N. Olson & S. J. Sollott: Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest, 113, 1535-49 (2004) (Pubitemid 39071677)
47. Cardone, M. H., N. Roy, H. R. Stennicke, G. S. Salvesen, T. F. Franke, E. Stanbridge, S. Frisch & J. C. Reed: Regulation of cell death protease caspase-9 by phosphorylation. Science, 282, 1318-21 (1998) (Pubitemid 28524494)
48. Datta, S. R., H. Dudek, X. Tao, S. Masters, H. Fu, Y. Gotoh & M. E. Greenberg: Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell, 91, 231-41 (1997) (Pubitemid 27456390)
49. Zauli, G., A. Bassini, M. Vitale, D. Gibellini, C. Celeghini, E. Caramelli, S. Pierpaoli, L. Guidotti & S. Capitani: Thrombopoietin enhances the alpha IIb beta 3-dependent adhesion of megakaryocytic cells to fibrinogen or fibronectin through PI 3 kinase. Blood, 89, 883-95 (1997) (Pubitemid 27121281)
50. Chanprasert, S., A. E. Geddis, C. Barroga, N. E. Fox & K. Kaushansky: Thrombopoietin (TPO)induces c-myc expression through a PI3K-and MAPK-dependent pathway that is not mediated by Akt, PKC (zeta)or mTOR in TPO-dependent cell lines and primary megakaryocytes. Cell Signal (2005)
51. Thompson, A., Y. Zhang, D. Kamen, C. W. Jackson, R. D. Cardiff & K. Ravid: Deregulated expression of c-myc in megakaryocytes of transgenic mice increases megakaryopoiesis and decreases polyploidization. J Biol Chem, 271, 22976-82 (1996) (Pubitemid 26314727)
52. Raslova, H., V. Baccini, L. Loussaief, B. Comba, J. Larghero, N. Debili & W. Vainchenker: Mammalian target of rapamycin (mTOR)regulates both proliferation of megakaryocyte progenitors and late stages of megakaryocyte differentiation. Blood (2005)
53. Johnson, G. L. & R. Lapadat: Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science, 298, 1911-2 (2002) (Pubitemid 35425238)
54. Rouyez, M. C., C. Boucheron, S. Gisselbrecht, I. Dusanter-Fourt & F. Porteu: Control of thrombopoietininduced megakaryocytic differentiation by the mitogenactivated protein kinase pathway. Mol Cell Biol, 17, 4991-5000 (1997) (Pubitemid 27357598)
55. Rojnuckarin, P., J. G. Drachman & K. Kaushansky: Thrombopoietin- induced activation of the mitogenactivated protein kinase (MAPK)pathway in normal megakaryocytes: role in endomitosis. Blood, 94, 1273-82 (1999) (Pubitemid 29380408)
56. Filippi, M. D., F. Porteu, F. L. Pesteur, V. Schiavon, G. A. Millot, W. Vainchenker, F. J. de Sauvage, A. Dubart Kupperschmitt & F. Sainteny: Requirement for mitogenactivated protein kinase activation in the response of embryonic stem cell-derived hematopoietic cells to thrombopoietin in vitro. Blood, 99, 1174-82 (2002) (Pubitemid 34547068)
57. Hamada, T., R. Mohle, J. Hesselgesser, J. Hoxie, R. L. Nachman, M. A. Moore & S. Rafii: Transendothelial migration of megakaryocytes in response to stromal cellderived factor 1 (SDF-1)enhances platelet formation. J Exp Med, 188, 539-48 (1998) (Pubitemid 28369143)
58. Bleul, C. C., R. C. Fuhlbrigge, J. M. Casasnovas, A. Aiuti & T. A. Springer: A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med, 184, 1101-9 (1996) (Pubitemid 26313567)
59. Hodohara, K., N. Fujii, N. Yamamoto & K. Kaushansky: Stromal cell-derived factor-1 (SDF-1)acts together with thrombopoietin to enhance the development of megakaryocytic progenitor cells (CFU-MK). Blood, 95, 769-75 (2000) (Pubitemid 30062694)
60. Guerriero, R., G. Mattia, U. Testa, C. Chelucci, G. Macioce, I. Casella, P. Samoggia, C. Peschle & H. J. Hassan: Stromal cell-derived factor 1alpha increases polyploidization of megakaryocytes generated by human hematopoietic progenitor cells. Blood, 97, 2587-95 (2001)
61. Garcia, J., Y. Ye, V. Arranz, C. Letourneux, G. Pezeron & F. Porteu: IEX-1: a new ERK substrate involved in both ERK survival activity and ERK activation. Embo J, 21, 5151-63 (2002)
62. Schilling, D., M. R. Pittelkow & R. Kumar: IEX-1, an immediate early gene, increases the rate of apoptosis in keratinocytes. Oncogene, 20, 7992-7 (2001) (Pubitemid 34001560)
63. Tanaka, T., M. Kurokawa, K. Ueki, K. Tanaka, Y. Imai, K. Mitani, K. Okazaki, N. Sagata, Y. Yazaki, Y. Shibata, T. Kadowaki & H. Hirai: The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation ability. Mol Cell Biol, 16, 3967-79 (1996) (Pubitemid 26199916)
64. Zhang, Y., J. R. Biggs & A. S. Kraft: Phorbol ester treatment of K562 cells regulates the transcriptional activity of AML1c through phosphorylation. J Biol Chem, 279, 53116-25 (2004) (Pubitemid 40051813)
65. Hamelin, V., C. Letourneux, P. H. Romeo, F. Porteu & M. Gaudry: Thrombopoietin regulates IEX-1 gene expression through ERK-induced AML1 phosphorylation. Blood (2005)
66. Lannutti, B. J., J. Minear, N. Blake & J. G. Drachman: Increased megakaryocytopoiesis in Lyn-deficient mice. Oncogene (2006)
67. Lannutti, B. J. & J. G. Drachman: Lyn tyrosine kinase regulates thrombopoietin-induced proliferation of hematopoietic cell lines and primary megakaryocytic progenitors. Blood, 103, 3736-43 (2004) (Pubitemid 38596289)
68. Lannutti, B. J., M. H. Shim, N. Blake, J. A. Reems & J. G. Drachman: Identification and activation of Src family kinases in primary megakaryocytes. Exp Hematol, 31, 1268-74 (2003) (Pubitemid 37510033)
69. Mehaffey, M. G., A. L. Newton, M. J. Gandhi, M. Crossley & J. G. Drachman: X-linked thrombocytopenia caused by a novel mutation of GATA-1. Blood, 98, 2681-8 (2001)
70. Cantor, A. B., S. G. Katz & S. H. Orkin: Distinct domains of the GATA-1 cofactor FOG-1 differentially influence erythroid versus megakaryocytic maturation. Mol Cell Biol, 22, 4268-79 (2002) (Pubitemid 34556595)
71. Chang, A. N., A. B. Cantor, Y. Fujiwara, M. B. Lodish, S. Droho, J. D. Crispino & S. H. Orkin: GATA-factor dependence of the multitype zinc-finger protein FOG-1 for its essential role in megakaryopoiesis. Proc Natl Acad Sci U S A, 99, 9237-42 (2002) (Pubitemid 34764597)
72. Crispino, J. D.: GATA1 mutations in Down syndrome: implications for biology and diagnosis of children with transient myeloproliferative disorder and acute megakaryoblastic leukemia. Pediatr Blood Cancer, 44, 40-4 (2005) (Pubitemid 39602564)
73. Greene, M. E., G. Mundschau, J. Wechsler, M. McDevitt, A. Gamis, J. Karp, S. Gurbuxani, R. Arceci & J. D. Crispino: Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome. Blood Cells Mol Dis, 31, 351-6 (2003) (Pubitemid 37433876)
74. Xu, G., M. Nagano, R. Kanezaki, T. Toki, Y. Hayashi, T. Taketani, T. Taki, T. Mitui, K. Koike, K. Kato, M. Imaizumi, I. Sekine, Y. Ikeda, R. Hanada, M. Sako, K. Kudo, S. Kojima, O. Ohneda, M. Yamamoto & E. Ito: Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome. Blood, 102, 2960-8 (2003) (Pubitemid 37248871)
75. Shimizu, R., K. Ohneda, J. D. Engel, C. D. Trainor & M. Yamamoto: Transgenic rescue of GATA-1-deficient mice with GATA-1 lacking a FOG-1 association site phenocopies patients with X-linked thrombocytopenia. Blood, 103, 2560-7 (2004) (Pubitemid 38393007)
76. Muntean, A. G. & J. D. Crispino: Differential requirements for the activation domain and FOG-interaction surface of GATA-1 in megakaryocyte gene expression and development. Blood, 106, 1223-31 (2005) (Pubitemid 41129583)
77. Stachura, D. L., S. T. Chou & M. J. Weiss: Early block to erythromegakaryocytic development conferred by loss of transcription factor GATA-1. Blood, 107, 87-97 (2006) (Pubitemid 43053528)
78. Iwasaki, H., S. Mizuno, R. A. Wells, A. B. Cantor, S. Watanabe & K. Akashi: GATA-1 converts lymphoid and myelomonocytic progenitors into the megakaryocyte/erythrocyte lineages. Immunity, 19, 451-62 (2003) (Pubitemid 37153420)
79. Eisbacher, M., M. L. Holmes, A. Newton, P. J. Hogg, L. M. Khachigian, M. Crossley & B. H. Chong: Proteinprotein interaction between Fli-1 and GATA-1 mediates synergistic expression of megakaryocyte-specific genes through cooperative DNA binding. Mol Cell Biol, 23, 3427-41 (2003) (Pubitemid 36539176)
80. Bastian, L. S., B. A. Kwiatkowski, J. Breininger, S. Danner & G. Roth: Regulation of the megakaryocytic glycoprotein IX promoter by the oncogenic Ets transcription factor Fli-1. Blood, 93, 2637-44 (1999) (Pubitemid 29181196)
81. Holmes, M. L., N. Bartle, M. Eisbacher & B. H. Chong: Cloning and analysis of the thrombopoietin-induced megakaryocyte-specific glycoprotein VI promoter and its regulation by GATA-1, Fli-1, and Sp1. J Biol Chem, 277, 48333-41 (2002) (Pubitemid 35470788)
82. Tamary, H., I. Yaniv, J. Stein, O. Dgany, Z. Shalev, T. Shechter, P. Resnitzky, D. Shaft, M. Zoldan, L. Kornreich, R. Levy, A. Cohen, R. A. Moser, J. Kapelushnik & H. Shalev: A clinical and molecular study of a Bedouin family with dysmegakaryopoiesis, mild anemia, and neutropenia cured by bone marrow transplantation. Eur J Haematol, 71, 196-203 (2003) (Pubitemid 37082843)
83. Jackers, P., G. Szalai, O. Moussa & D. K. Watson: Ets-dependent regulation of target gene expression during megakaryopoiesis. J Biol Chem, 279, 52183-90 (2004) (Pubitemid 39656592)
84. Wang, X., J. D. Crispino, D. L. Letting, M. Nakazawa, M. Poncz & G. A. Blobel: Control of megakaryocyte-specific gene expression by GATA-1 and FOG-1: role of Ets transcription factors. Embo J, 21, 5225-34 (2002)
85. Martin, D. I. & S. H. Orkin: Transcriptional activation and DNA binding by the erythroid factor GF-1/NF-E1/Eryf 1. Genes Dev, 4, 1886-98 (1990) (Pubitemid 120012590)
86. Fox, A. H., C. Liew, M. Holmes, K. Kowalski, J. Mackay & M. Crossley: Transcriptional cofactors of the FOG family interact with GATA proteins by means of multiple zinc fingers. Embo J, 18, 2812-22 (1999) (Pubitemid 29233953)
87. Balduini, C. L., A. Iolascon & A. Savoia: Inherited thrombocytopenias: from genes to therapy. Haematologica, 87, 860-80 (2002) (Pubitemid 34851558)
88. Niitsu, N., Y. Yamamoto-Yamaguchi, H. Miyoshi, K. Shimizu, M. Ohki, M. Umeda & Y. Honma: AML1a but not AML1b inhibits erythroid differentiation induced by sodium butyrate and enhances the megakaryocytic differentiation of K562 leukemia cells. Cell Growth Differ, 8, 319-26 (1997) (Pubitemid 27273054)
89. Elagib, K. E., F. K. Racke, M. Mogass, R. Khetawat, L. L. Delehanty & A. N. Goldfarb: RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation. Blood, 101, 4333-41 (2003) (Pubitemid 36857797)
90. Miyamoto, T., K. Nagafuji, K. Akashi, M. Harada, T. Kyo, T. Akashi, K. Takenaka, S. Mizuno, H. Gondo, T. Okamura, H. Dohy & Y. Niho: Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t (8;21)acute myelogenous leukemia. Blood, 87, 4789-96 (1996) (Pubitemid 26162380)
91. Yanagida, M., M. Osato, N. Yamashita, H. Liqun, B. Jacob, F. Wu, X. Cao, T. Nakamura, T. Yokomizo, S. Takahashi, M. Yamamoto, K. Shigesada & Y. Ito: Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice. Oncogene, 24, 4477-85 (2005) (Pubitemid 41032611)
92. Levin, J., J. P. Peng, G. R. Baker, J. L. Villeval, P. Lecine, S. A. Burstein & R. A. Shivdasani: Pathophysiology of thrombocytopenia and anemia in mice lacking transcription factor NF-E2. Blood, 94, 3037-47 (1999) (Pubitemid 29512708)
93. Romeo, P. H., M. H. Prandini, V. Joulin, V. Mignotte, M. Prenant, W. Vainchenker, G. Marguerie & G. Uzan: Megakaryocytic and erythrocytic lineages share specific transcription factors. Nature, 344, 447-9 (1990)
94. Andrews, N. C., H. Erdjument-Bromage, M. B. Davidson, P. Tempst & S. H. Orkin: Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper protein. Nature, 362, 722-8 (1993) (Pubitemid 23125974)
95. Terui, K., Y. Takahashi, J. Kitazawa, T. Toki, M. Yokoyama & E. Ito: Expression of transcription factors during megakaryocytic differentiation of CD34+ cells from human cord blood induced by thrombopoietin. Tohoku J Exp Med, 192, 259-73 (2000) (Pubitemid 33621616)
96. Shivdasani, R. A., M. F. Rosenblatt, D. Zucker-Franklin, C. W. Jackson, P. Hunt, C. J. Saris & S. H. Orkin: Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell, 81, 695-704 (1995)
97. Shivdasani, R. A. & S. H. Orkin: Erythropoiesis and globin gene expression in mice lacking the transcription factor NF-E2. Proc Natl Acad Sci U S A, 92, 8690-4 (1995)
98. Lecine, P., J. L. Villeval, P. Vyas, B. Swencki, Y. Xu & R. A. Shivdasani: Mice lacking transcription factor NF-E2 provide in vivo validation of the proplatelet model of thrombocytopoiesis and show a platelet production defect that is intrinsic to megakaryocytes. Blood, 92, 1608-16 (1998) (Pubitemid 28406864)
99. Carlino, J. A., H. R. Higley, J. R. Creson, P. D. Avis, Y. Ogawa & L. R. Ellingsworth: Transforming growth factor beta 1 systemically modulates granuloid, erythroid, lymphoid, and thrombocytic cells in mice. Exp Hematol, 20, 943-50 (1992)
100. Catani, L., M. Amabile, S. Luatti, L. Valdre, N. Vianelli, G. Martinelli & S. Tura: Interleukin-4 downregulates nuclear factor-erythroid 2 (NF-E2)expression in primary megakaryocytes and in megakaryoblastic cell lines. Stem Cells, 19, 339-47 (2001) (Pubitemid 32721101)
101. Letterio, J. J., A. G. Geiser, A. B. Kulkarni, H. Dang, L. Kong, T. Nakabayashi, C. L. Mackall, R. E. Gress & A. B. Roberts: Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression. J Clin Invest, 98, 2109-19 (1996) (Pubitemid 26376300)
102. Swank, R. T., S. Y. Jiang, M. Reddington, J. Conway, D. Stephenson, M. P. McGarry & E. K. Novak: Inherited abnormalities in platelet organelles and platelet formation and associated altered expression of low molecular weight guanosine triphosphate-binding proteins in the mouse pigment mutant gunmetal. Blood, 81, 2626-35 (1993) (Pubitemid 23147566)
103. Nagata, Y., J. Yoshikawa, A. Hashimoto, M. Yamamoto, A. H. Payne & K. Todokoro: Proplatelet formation of megakaryocytes is triggered by autocrinesynthesized estradiol. Genes Dev, 17, 2864-9 (2003) (Pubitemid 37523151)
104. Deveaux, S., A. Filipe, V. Lemarchandel, J. Ghysdael, P. H. Romeo & V. Mignotte: Analysis of the thrombopoietin receptor (MPL)promoter implicates GATA and Ets proteins in the coregulation of megakaryocyte-specific genes. Blood, 87, 4678-85 (1996) (Pubitemid 26162367)
105. Hodge, D. R., D. Li, S. M. Qi & W. L. Farrar: IL-6 induces expression of the Fli-1 proto-oncogene via STAT3. Biochem Biophys Res Commun, 292, 287-91 (2002) (Pubitemid 34687362)
106. Sakurai, T., T. Yamada, F. Kihara-Negishi, S. Teramoto, Y. Sato, T. Izawa & T. Oikawa: Effects of overexpression of the Ets family transcription factor TEL on cell growth and differentiation of K562 cells. Int J Oncol, 22, 1327-33 (2003)
107. Athanasiou, M., G. Mavrothalassitis, L. Sun-Hoffman & D. G. Blair: FLI-1 is a suppressor of erythroid differentiation in human hematopoietic cells. Leukemia, 14, 439-45 (2000) (Pubitemid 30142868)
108. Takahashi, W., K. Sasaki, N. Kvomatsu & K. Mitani: TEL/ETV6 accelerates erythroid differentiation and inhibits megakaryocytic maturation in a human leukemia cell line UT-7/GM. Cancer Sci, 96, 340-8 (2005) (Pubitemid 41007468)
109. Tong, W. & H. F. Lodish: Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis. J Exp Med, 200, 569-80 (2004) (Pubitemid 39258306)
110. Toki, T., F. Katsuoka, R. Kanezaki, G. Xu, H. Kurotaki, J. Sun, T. Kamio, S. Watanabe, S. Tandai, K. Terui, S. Yagihashi, N. Komatsu, K. Igarashi, M. Yamamoto & E. Ito: Transgenic expression of BACH1 transcription factor results in megakaryocytic impairment. Blood, 105, 3100-8 (2005)
111. Hu, W., A. S. Philips, J. C. Kwok, M. Eisbacher & B. H. Chong: Identification of nuclear import and export signals within Fli-1: roles of the nuclear import signals in Fli-1-dependent activation of megakaryocyte-specific promoters. Mol Cell Biol, 25, 3087-108 (2005) (Pubitemid 40464312)
112. Hart, A., F. Melet, P. Grossfeld, K. Chien, C. Jones, A. Tunnacliffe, R. Favier & A. Bernstein: Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Immunity, 13, 167-77 (2000)
113. Spyropoulos, D. D., P. N. Pharr, K. R. Lavenburg, P. Jackers, T. S. Papas, M. Ogawa & D. K. Watson: Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor. Mol Cell Biol, 20, 5643-52 (2000) (Pubitemid 30482898)
114. Kawada, H., T. Ito, P. N. Pharr, D. D. Spyropoulos, D. K. Watson & M. Ogawa: Defective megakaryopoiesis and abnormal erythroid development in Fli-1 gene-targeted mice. Int J Hematol, 73, 463-8 (2001) (Pubitemid 33758879)
115. Igarashi, K., K. Kataoka, K. Itoh, N. Hayashi, M. Nishizawa & M. Yamamoto: Regulation of transcription by dimerization of erythroid factor NF-E2 p45 with small Maf proteins. Nature, 367, 568-72 (1994) (Pubitemid 24055517)
116. Mohler, J., K. Vani, S. Leung & A. Epstein: Segmentally restricted, cephalic expression of a leucine zipper gene during Drosophila embryogenesis. Mech Dev, 34, 3-9 (1991)